Hakutulokset - Igor Espinoza‐Delgado

  • Näytetään 1 - 20 yhteensä 20 tuloksesta
Tarkenna hakua
  1. 1
    Clinical Toxicities of Histone Deacetylase Inhibitors

    Clinical Toxicities of Histone Deacetylase Inhibitors Tekijä Srividya Subramanian, Susan E. Bates, James R. Wright, Igor Espinoza‐Delgado, Richard Piekarz

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Transforming growth factor beta downregulates interleukin-1 (IL-1)- induced IL-6 production by human monocytes

    Transforming growth factor beta downregulates interleukin-1 (IL-1)- induced IL-6 production by human monocytes Tekijä Tiziana Musso, Igor Espinoza‐Delgado, Kari Pulkki, GL Gusella, DL Longo, Luigi Varesio

    Julkaistu 1990
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes.

    IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes. Tekijä G. Luca Gusella, Tiziana Musso, Maria Carla Bosco, Igor Espinoza‐Delgado, Koji Matsushima, Luigi Varesio

    Julkaistu 1993
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Expression and role of p75 interleukin 2 receptor on human monocytes.

    Expression and role of p75 interleukin 2 receptor on human monocytes. Tekijä Igor Espinoza‐Delgado, John R. Ortaldo, Robin Winkler-Pickett, Kazuo Sugamura, Luigi Varesio, D L Longo

    Julkaistu 1990
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma

    Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma Tekijä Suresh S. Ramalingam, Chandra P. Belani, Christopher Ruel, Paul Frankel, Barbara J. Gitlitz, Marianna Koczywas, Igor Espinoza‐Delgado, David R. Gandara

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    A phase 2 study of vorinostat in acute myeloid leukemia

    A phase 2 study of vorinostat in acute myeloid leukemia Tekijä Élise Schaefer, Arturo Loaiza‐Bonilla, Mark Juckett, John F. DiPersio, Vivek Roy, James L. Slack, Wenting Wu, K. M. Laumann, Igor Espinoza‐Delgado, S. D. Gore

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

    Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer Tekijä Suresh S. Ramalingam, Michael L. Maitland, Paul Frankel, Athanassios Argiris, Marianna Koczywas, Barbara J. Gitlitz, Sachdev Thomas, Igor Espinoza‐Delgado, Everett E. Vokes, David R. Gandara, Chandra P. Belani

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer

    A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer Tekijä Marwan Fakih, Lakshmi Pendyala, Gerald J. Fetterly, K. Toth, James A. Zwiebel, Igor Espinoza‐Delgado, Alan Litwin, Youcef M. Rustum, Mary Ellen Ross, Julianne L. Holleran, Merrill J. Egorin

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors

    Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors Tekijä Giuseppe Giaccone, Arun Rajan, Arlene Berman, Ronan J. Kelly, Éva Szabó, Ariel López-Chávez, Jane B. Trepel, Min-Jung Lee, Liang Cao, Igor Espinoza‐Delgado, John Spittler, Patrick J. Loehrer

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia

    Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid... Tekijä Ivana Gojo, Ming Tan, Hong‐Bin Fang, Mariola Sadowska, Rena G. Lapidus, Maria R. Baer, France Carrier, Jan H. Beumer, Bean N. Anyang, Rahul Srivastava, Igor Espinoza‐Delgado, Douglas D. Ross

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

    Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma Tekijä Mark Kirschbaum, Paul Frankel, Leslie Popplewell, Jasmine Zain, Maria Delioukina, Vinod Pullarkat, Deron Matsuoka, Bernadette Pulone, A Rotter, Igor Espinoza‐Delgado, Auayporn Nademanee, Stephen J. Forman, David R. Gandara, Edward M. Newman

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study

    Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study Tekijä Anne M. Traynor, Sarita Dubey, Jens C. Eickhoff, Jill Kolesar, Kathleen Schell, Michael S. Huie, David L. Groteluschen, Sarah M. Marcotte, Courtney M. Hallahan, Hilary Weeks, George Wilding, Igor Espinoza‐Delgado, Joan H. Schiller

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

    A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916) Tekijä Jodi A. Muscal, Patrick A. Thompson, Terzah M. Horton, Ashish M. Ingle, Charlotte H. Ahern, Renee M. McGovern, Joel M. Reid, Matthew M. Ames, Igor Espinoza‐Delgado, Brenda J. Weigel, Susan M. Blaney

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma

    Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma Tekijä Ashraf Badros, Angelika M. Burger, Sunita Philip, Rubén Niesvizky, Sarah Kolla, Olga Goloubeva, Carolynn Harris, James A. Zwiebel, James R. Wright, Igor Espinoza‐Delgado, Maria R. Baer, Julianne L. Holleran, Merrill J. Egorin, Steven Grant

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

    Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo Tekijä B Ramaswamy, Warren Fiskus, Barbara Cohen, C. Pellegrino, Dawn L. Hershman, Ellen Chuang, Thehang Luu, George Somlo, Matthew P. Goetz, Ramona F. Swaby, Charles L. Shapiro, Vered Stearns, PJ Christos, Igor Espinoza‐Delgado, Kapil N. Bhalla, Joseph A. Sparano

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas

    Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas Tekijä Anastasios Stathis, Sébastien J. Hotte, Eric X. Chen, Holger W. Hirte, Amit M. Oza, Patrícia Moretto, Sheila Webster, Anne Laughlin, Lee-Anne Stayner, Shauna McGill, Lisa Wang, Wenjiang Zhang, Igor Espinoza‐Delgado, Julianne L. Holleran, Merrill J. Egorin, Lillian L. Siu

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer

    Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer Tekijä Rosalyn A. Juergens, John Wrangle, Frank P. Vendetti, Sara C. Murphy, Ming Zhao, Barbara Coleman, Rosa Sebree, Kristen Rodgers, Craig M. Hooker, Noreli Franco, Beverly Lee, Salina Tsai, Igor Espinoza Delgado, Michelle A. Rudek, Steven A. Belinsky, James G. Herman, Stephen B. Baylin, Malcolm V. Brock, Charles M. Rudin

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Summary Statement Novel Agents in the Treatment of Lung Cancer: Fifth Cambridge Conference Assessing Opportunities for Combination Therapy

    Summary Statement Novel Agents in the Treatment of Lung Cancer: Fifth Cambridge Conference Assessing Opportunities for Combination Therapy Tekijä Thomas J. Lynch, George R. Blumenschein, Jeffrey A. Engelman, Igor Espinoza‐Delgado, Ramaswamy Govindan, Jeff Hanke, Nasser H. Hanna, John V. Heymach, Fred R. Hirsch, Pasi A. Jänne, Rogério Lilenbaum, Ronald B. Natale, Gregory J. Riely, Lecia V. Sequist, Geoffrey I. Shapiro, Alice T. Shaw, Frances A. Shepherd, Mark A. Socinski, A. Gregory Sorensen, Heather A. Wakelee, Aaron Weitzman

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies

    Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies Tekijä Tamer E. Fandy, James G. Herman, Patrick Kerns, Anchalee Jiemjit, Elizabeth A. Sugar, Si-Ho Choi, Allen S. Yang, Timothy Aucott, Tianna Dauses, Rosalie Odchimar-Reissig, Jonathan D. Licht, Melanie J. McConnell, Chris A. Nasrallah, Marianne K. H. Kim, Weijia Zhang, Yezou Sun, Anthony J. Murgo, Igor Espinoza‐Delgado, Katharine Oteiza, Ibitayo Owoeye, Lewis R. Silverman, Steven D. Gore, Hetty E. Carraway

    Julkaistu 2009
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03

    Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03 Tekijä Eudocia Q. Lee, Vinay K. Puduvalli, Joel M. Reid, John G. Kuhn, Kathleen R. Lamborn, Timothy F. Cloughesy, Susan M. Chang, Jan Drappatz, W. K. Alfred Yung, Mark R. Gilbert, H. Ian Robins, Frank S. Lieberman, Andrew B. Lassman, Renee M. McGovern, Jihong Xu, Serena Desideri, Xiabu Ye, Matthew M. Ames, Igor Espinoza‐Delgado, Michael D. Prados, Patrick Y. Wen

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: